Benefit from autologous stem cell transplantation in primary refractory myeloma? Different outcomes in progressive versus stable disease. [artículo]
Por: Lahuerta Palacios, Juan José [Hematología y Hemoterapia]
.
Colaborador(es): Servicio de Hematología y Hemoterapia.
Editor: Haematologica, 2012Descripción: 97(4):616-21.Recursos en línea: Acceso libre Resumen: BACKGROUND: Several studies of autologous stem cell transplantation in primary refractory myeloma have produced encouraging results. However, the outcome of primary refractory patients with stable disease has not been analyzed separately from the outcome of patients with progressive disease.
| Tipo de ítem | Ubicación actual | Signatura | Estado | Fecha de vencimiento |
|---|---|---|---|---|
Artículo
|
PC7724 (Navegar estantería) | Disponible |
Formato Vancouver:
Rosiñol L, García-Sanz R, Lahuerta JJ, Hernández-García M, Granell M, de la Rubia J, et al. Benefit from autologous stem cell
transplantation in primary refractory myeloma? Different outcomes in progressive versus stable disease. Haematologica. 2012 Apr;97(4):616-21.
PMID: 22058223
Contiene 34 referencias
BACKGROUND: Several studies of autologous stem cell transplantation in primary refractory myeloma have produced encouraging results. However, the outcome of primary refractory patients with stable disease has not been analyzed separately from the outcome of patients with progressive disease.
No hay comentarios para este ejemplar.